Triple vasodilator therapy in pulmonary arterial hypertension associated with congenital heart disease

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

(2022) Marc Humbert et al.   EUROPEAN HEART JOURNAL

Long-term course of pulmonary arterial hypertension in adults with congenital heart disease under targeted therapy: a retrospective analysis of a single tertiary center

(2022) Katharina Strack et al.   Cardiovascular Diagnosis and Therapy

COMPERA 2.0: A refined 4-strata risk assessment model for pulmonary arterial hypertension

(2021) Marius M. Hoeper et al.   EUROPEAN RESPIRATORY JOURNAL

External validation of a refined 4-strata risk assessment score from the French pulmonary hypertension Registry

(2021) Athénaïs Boucly et al.   EUROPEAN RESPIRATORY JOURNAL

Three- Versus Two-Drug Therapy for Patients With Newly Diagnosed Pulmonary Arterial Hypertension

(2021) Kelly M. Chin et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Medical treatment of pulmonary hypertension in adults with congenital heart disease: updated and extended results from the International COMPERA-CHD Registry

(2021) Ann-Sophie Kaemmerer et al.   Cardiovascular Diagnosis and Therapy

2020 ESC Guidelines for the management of adult congenital heart disease

(2020) Helmut Baumgartner et al.   EUROPEAN HEART JOURNAL

A single-centre, placebo-controlled, double-blind randomised cross-over study of nebulised iloprost in patients with Eisenmenger syndrome: A pilot study

(2019) Heba Nashat et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

The effects of parenteral prostacycline therapy as add-on treatment to oral compounds in Eisenmenger syndrome

(2019) Michele D'Alto et al.   EUROPEAN RESPIRATORY JOURNAL

Real-life experience of inhaled iloprost for patients with pulmonary arterial hypertension: Insights from the Spanish REHAP registry

(2018) Roberto Del Pozo et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

(2015) Nazzareno Galiè et al.   EUROPEAN HEART JOURNAL

Riociguat for pulmonary arterial hypertension associated with congenital heart disease

(2015) Stephan Rosenkranz et al.   HEART

Pulmonary hypertension and congenital heart disease: An insight from the REHAP National Registry

(2015) Rafael Alonso-Gonzalez et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Selexipag for the Treatment of Pulmonary Arterial Hypertension

(2015) Olivier Sitbon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension

(2015) Nazzareno Galiè et al.   NEW ENGLAND JOURNAL OF MEDICINE

Survival prospects of treatment naïve patients with Eisenmenger: a systematic review of the literature and report of own experience

(2014) Gerhard-Paul Diller et al.   HEART

Contemporary prevalence of pulmonary arterial hypertension in adult congenital heart disease following the updated clinical classification

(2014) Annelieke C.M.J. van Riel et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Disease targeting therapies in patients with Eisenmenger syndrome: Response to treatment and long-term efficiency

(2012) Gerhard-Paul Diller et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Bosentan–sildenafil association in patients with congenital heart disease-related pulmonary arterial hypertension and Eisenmenger physiology

(2010) Michele D'Alto et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY